Recommendations for genetic testing to reduce the incidence of anthracycline-induced cardiotoxicity
出版年份 2016 全文链接
标题
Recommendations for genetic testing to reduce the incidence of anthracycline-induced cardiotoxicity
作者
关键词
-
出版物
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Volume 82, Issue 3, Pages 683-695
出版商
Wiley
发表日期
2016-05-20
DOI
10.1111/bcp.13008
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Clinical and genetic risk factors for epirubicin-induced cardiac toxicity in early breast cancer patients
- (2015) Christof Vulsteke et al. BREAST CANCER RESEARCH AND TREATMENT
- A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer
- (2015) Folefac Aminkeng et al. NATURE GENETICS
- Association of NADPH oxidase polymorphisms with anthracycline-induced cardiotoxicity in the RICOVER-60 trial of patients with aggressive CD20+ B-cell lymphoma
- (2015) Annegret Reichwagen et al. PHARMACOGENOMICS
- Genetic variants inSLC22A17 and SLC22A7are associated with anthracycline-induced cardiotoxicity in children
- (2015) Henk Visscher et al. PHARMACOGENOMICS
- Polymorphisms of ABCC5 and NOS3 genes influence doxorubicin cardiotoxicity in survivors of childhood acute lymphoblastic leukemia
- (2015) M Krajinovic et al. PHARMACOGENOMICS JOURNAL
- Recommendations for HLA-B*15:02 and HLA-A*31:01 genetic testing to reduce the risk of carbamazepine-induced hypersensitivity reactions
- (2014) Ursula Amstutz et al. EPILEPSIA
- Hyaluronan Synthase 3 Variant and Anthracycline-Related Cardiomyopathy: A Report From the Children's Oncology Group
- (2014) Xuexia Wang et al. JOURNAL OF CLINICAL ONCOLOGY
- Assessing anthracycline-treated childhood cancer survivors with advanced stress echocardiography
- (2014) A. Blythe Ryerson et al. PEDIATRIC BLOOD & CANCER
- Impact of hemochromatosis gene mutations on cardiac status in doxorubicin-treated survivors of childhood high-risk leukemia
- (2013) Steven E. Lipshultz et al. CANCER
- Educational Paper: Decreasing the burden of cardiovascular disease in childhood cancer survivors: An update for the pediatrician
- (2013) Rejane F. Dillenburg et al. EUROPEAN JOURNAL OF PEDIATRICS
- Association of Anthracycline-Related Cardiac Histological Lesions With NADPH Oxidase Functional Polymorphisms
- (2013) A. Cascales et al. ONCOLOGIST
- Validation of variants inSLC28A3andUGT1A6as genetic markers predictive of anthracycline-induced cardiotoxicity in children
- (2013) H. Visscher et al. PEDIATRIC BLOOD & CANCER
- Retinoid signaling in control of progenitor cell differentiation during mouse development
- (2013) Gregg Duester SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- A discovery study of daunorubicin induced cardiotoxicity in a sample of acute myeloid leukemia patients prioritizes P450 oxidoreductase polymorphisms as a potential risk factor
- (2013) Joanna M. Lubieniecka et al. Frontiers in Genetics
- Single-Nucleotide Polymorphisms in Aldo-Keto and Carbonyl Reductase Genes Are Not Associated with Acute Cardiotoxicity after Daunorubicin Chemotherapy
- (2012) J. M. Lubieniecka et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- RAR is essential for retinoic acid induced chromatin remodeling and transcriptional activation in embryonic stem cells
- (2012) V. Kashyap et al. JOURNAL OF CELL SCIENCE
- The relationship between changes in functional cardiac parameters following anthracycline therapy and carbonyl reductase 3 and glutathione S transferase Pi polymorphisms
- (2012) Bilge Volkan Salanci et al. JOURNAL OF CHEMOTHERAPY
- Retinoic Acid Signalling Is Activated in the Postischemic Heart and May Influence Remodelling
- (2012) Dusan Bilbija et al. PLoS One
- Unexpected doxorubicin-mediated cardiotoxicity in sisters: Possible role of polymorphisms in histamine n-methyl transferase
- (2012) Kamakshi Sachidanandam et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Guide to Receptors and Channels (GRAC), 5th edition
- (2011) SPH Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- Germline genetic polymorphisms may influence chemotherapy response and disease outcome in osteosarcoma
- (2011) Rachael E. Windsor et al. CANCER
- ABCC1polymorphisms in anthracycline-induced cardiotoxicity in childhood acute lymphoblastic leukaemia
- (2011) Agnes F. Semsei et al. CELL BIOLOGY INTERNATIONAL
- Retinoic Acid Production by Endocardium and Epicardium Is an Injury Response Essential for Zebrafish Heart Regeneration
- (2011) Kazu Kikuchi et al. DEVELOPMENTAL CELL
- Pharmacogenomic Prediction of Anthracycline-Induced Cardiotoxicity in Children
- (2011) Henk Visscher et al. JOURNAL OF CLINICAL ONCOLOGY
- Anthracycline-Related Cardiomyopathy After Childhood Cancer: Role of Polymorphisms in Carbonyl Reductase Genes—A Report From the Children's Oncology Group
- (2011) Javier G. Blanco et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical and genetic determinants of anthracycline-induced cardiac iron accumulation
- (2010) Almudena Cascales et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Role of Cancer Treatment in Long-Term Overall and Cardiovascular Mortality After Childhood Cancer
- (2010) Markhaba Tukenova et al. JOURNAL OF CLINICAL ONCOLOGY
- Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial
- (2010) Steven E Lipshultz et al. LANCET ONCOLOGY
- Genetics and Beyond – The Transcriptome of Human Monocytes and Disease Susceptibility
- (2010) Tanja Zeller et al. PLoS One
- New Developments in Anthracycline-Induced Cardiotoxicity
- (2009) A. Mordente et al. CURRENT MEDICINAL CHEMISTRY
- Analysis of the host pharmacogenetic background for prediction of outcome and toxicity in diffuse large B-cell lymphoma treated with R-CHOP21
- (2009) D Rossi et al. LEUKEMIA
- Influence of the polymorphism in candidate genes on late cardiac damage in patients treated due to acute leukemia in childhood
- (2009) Vladan Rajić et al. LEUKEMIA & LYMPHOMA
- Genetic polymorphisms in the carbonyl reductase 3 geneCBR3 and the NAD(P)H:quinone oxidoreductase 1 geneNQO1 in patients who developed anthracycline-related congestive heart failure after childhood cancer
- (2008) Javier G. Blanco et al. CANCER
- Absence of Secondary Malignant Neoplasms in Children With High-Risk Acute Lymphoblastic Leukemia Treated With Dexrazoxane
- (2008) Elly V. Barry et al. JOURNAL OF CLINICAL ONCOLOGY
- Monitoring of Anthracycline-Induced Cardiotoxicity
- (2007) Abigail Jannazzo et al. ANNALS OF PHARMACOTHERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started